NINO RAINUSSO to Child
This is a "connection" page, showing publications NINO RAINUSSO has written about Child.
Connection Strength
0.340
-
Comment on: Parents' responses to prognostic disclosure at diagnosis of a child with a high-risk brain tumor: Analysis of clinician-parent interactions and implications for clinical practice. The role of reflection in dealing with uncertainty. Pediatr Blood Cancer. 2021 08; 68(8):e29057.
Score: 0.044
-
Splenic embolization to continue chemotherapy in a child with hypersplenism-related thrombocytopenia. Pediatr Blood Cancer. 2021 02; 68(2):e28613.
Score: 0.042
-
Neuroblastoma of the Bone and Bone Marrow Without an Apparent Primary Site: Report of 4 Cases With Long-term Follow-up. Pediatr Dev Pathol. 2019 Jul-Aug; 22(4):329-333.
Score: 0.038
-
Generation of patient-derived tumor xenografts from percutaneous tumor biopsies in children with bone sarcomas. Pediatr Blood Cancer. 2019 04; 66(4):e27579.
Score: 0.037
-
Pediatric Solid Tumors in Children and Adolescents: An Overview. Pediatr Rev. 2018 Sep; 39(9):444-453.
Score: 0.037
-
Cardiovascular Toxicity in Patients Treated for Childhood Cancer: A Scientific Statement From the American Heart Association. Circulation. 2025 Apr 15; 151(15):e926-e943.
Score: 0.014
-
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatr Blood Cancer. 2025 Apr; 72(4):e31557.
Score: 0.014
-
Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study. Radiother Oncol. 2024 06; 195:110270.
Score: 0.014
-
Correlating decline in left ventricular ejection fraction and longitudinal strain in pediatric cancer patients. Int J Cardiovasc Imaging. 2023 Apr; 39(4):747-755.
Score: 0.012
-
Ventricular assist device support for children with chemotherapy-induced cardiomyopathy and advanced heart failure: Perspectives gained from a single-center experience. Pediatr Transplant. 2022 08; 26(5):e14286.
Score: 0.012
-
Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood. J Pathol. 2021 09; 255(1):52-61.
Score: 0.011
-
Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma. Cancer Res. 2021 01 01; 81(1):199-212.
Score: 0.011
-
Assessing the left atrium of childhood cancer survivors. Int J Cardiovasc Imaging. 2021 Jan; 37(1):155-162.
Score: 0.011
-
Improving reproducibility of left ventricular ejection fraction in pediatric oncology patients: less is more. Int J Cardiovasc Imaging. 2020 Oct; 36(10):1887-1895.
Score: 0.010
-
Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma. Pediatr Blood Cancer. 2020 04; 67(4):e28123.
Score: 0.010
-
Local therapy to distant metastatic sites in stage IV rhabdomyosarcoma. Pediatr Blood Cancer. 2018 Feb; 65(2).
Score: 0.009
-
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015 May 20; 33(15):1688-96.
Score: 0.007
-
Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma. Cancer Med. 2015 Jul; 4(7):977-88.
Score: 0.007